Due to the oligopolistic nature of the epigenetics drugs and diagnostic techniques market, players are trying to push their drugs for various oncological indications to fend off the competition. The three companies who were the only key competitors in the global epigenetics drugs and diagnosis technology market in 2011 are Celegene Corporation, Eisai Pharmaceuticals, and Merck. Celegene is expected to maintain ... Read more

Epigenetics drugs and diagnostic technologies are revolutionary tools used in personalized medicine and biomedical research. They enable identification of molecular biomarkers for detection of diseases like cancer at an early stage and enable targeted drug therapies. Advantages include non-invasive detection, high sensitivity and specificity. The global Epigenetics Drugs and Diagnostic Technologies Market is estimated to be valued at US$ 12.91 Bn in 2024 and is expected to exhibit a ... Read more